UC San Diego Health Sciences schools, institutes and centers are at the forefront of discovery and transformation.
Six University of California campuses, in coordination with two national labs and more than one dozen industry partners, have formed the University of California-National Labs Antiviral Treatments Targeting All Coronaviruses and Key RNA viruses Consortium to prepare for and prevent future pandemics.
UC San Diego researchers report successfully removing the nucleus from a type of ubiquitous cell, then using the genetically engineered cell as a unique cargo-carrier to deliver therapeutics precisely to diseased tissues.Researchers at University of California San Diego School of Medicine and Moores
A pioneering mentorship program at UC San Diego Health Sciences improved faculty satisfaction, especially among underrepresented faculty. The program serves as a successful model for other universities and medical schools looking to improve faculty diversity and success.
Marking its 30th anniversary and her enduring interest and support, philanthropist Darlene Shiley has given a $10 million gift for the clinical space expansion of the Shiley Eye Institute at UC San Diego Health.
Computer simulations from UC San Diego School of Medicine reveal the action mechanism and substrate specificity of an important blood enzyme. These findings open the door for new therapeutics against cardiovascular disease, and further support a unifying theory of phospholipase function.
Researchers at UC San Diego School of Medicine pinpoint the regions of the brain and neural mechanisms responsible for normal or impaired development of a child’s response to baby talk and why infants with autism do not typically respond well.
Forbes, May 29
San Diego Union Tribune, May 28
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
